ArticleGenes & nutrition2025
Association of non-alcoholic fatty liver polygenic risk scores with the incident and progressive non-alcoholic fatty liver disease in Chinese population.
Article in Genes & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundNonalcoholic fatty liver disease (NAFLD) is an escalating health concern, with genetic factors playing a substantial role. This study aimed to establish and validate a polygenic risk score for East Asian populations (PRS-EA).
methodsA meta-analysis of genome-wide association studies on NAFLD in East Asian populations was conducted to develop a PRS-EA model. This model was subsequently validated in the Kailuan cohort by exploring its association with NAFLD development and progression.
resultsA PRS-EA model involving four SNPs (rs2896019, rs3810622, rs58542926, and rs1260326) was constructed. Individuals with PRS-EA scores exceeding 2.33 were associated with a 53% (95% confidence interval, 3%-126%) increased risk of NAFLD development and 50% (95% confidence interval: 3%-120%) of NAFLD progression. A positive joint association was observed between higher PRS and lipid dysfunction in relation to NAFLD occurrence. Hypertension was found to amplify the association between higher PRS and NAFLD progression (hazard ratio: 3.07 vs. 1.22, P for interaction=0.015).
conclusionThis study developed a PRS model specific to East Asian populations, highlighting the potential utility of PRS-EA in assessing and managing NAFLD risk, particularly in individuals with lipid metabolic dysfunction and hypertension.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.